Coronary involvement in infants with Kawasaki disease treated with intravenous γ-globulin

被引:10
作者
Moreno, Noelia [3 ]
Mendez-Echevarria, Ana [1 ,3 ]
de Inocencio, Jaime [2 ]
del Castillo, Fernando [3 ]
Baquero-Artigao, Fernando [3 ]
Jesus Garcia-Miguel, Maria [3 ]
Isabel de Jose, Maria [3 ]
Aracil, Javier [3 ]
机构
[1] Hosp Infantil La Paz, Pediat Infect Dis Unit, Madrid 28046, Spain
[2] CS Estrecho Corea, Madrid, Spain
[3] Childrens Hosp La Paz, Pediat Infect Dis Unit, Madrid, Spain
关键词
Kawasaki disease; Infant; coronary artery disease;
D O I
10.1007/s00246-007-9068-0
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Aim To analyze the clinical spectrum and the incidence of coronary involvement in infants with typical Kawasaki's disease (KD). Patients and Methods A retrospective study was performed on children one year of age or younger diagnosed from February 1992 to January 2006 with typical KD. Children with incomplete forms of the disease were not included. Results Twenty-five infants were diagnosed with KD during the study period. The median age of the patients was 10 months (range, 4-12 months). All children but one received intravenous gammaglobulin (IVIG), 84% before the 10th day of disease. Seven patients (28%) required the administration of more than one dose of IVIG, because persistence of fever. Coronary artery disease (CAD) was recorded in 6 cases (24%), five of them being boys. All patients with CAD were treated with ASA plus IVIG and 84% of them received this therapy within the first 10 days of the KD onset. Conclusions In spite of the exclusion of our study of incomplete presentations and of an early administration of IVIG in our patients, we have observed a high rate of infants who developed CAD, which is similar to the one reported in children who do not receive IVIG.
引用
收藏
页码:31 / 35
页数:5
相关论文
共 18 条
[1]   Kawasaki syndrome and risk factors for coronary artery abnormalities - United States, 1994-2003 [J].
Belay, ED ;
Maddox, RA ;
Holman, RC ;
Curns, AT ;
Ballah, K ;
Schonberger, LB .
PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2006, 25 (03) :245-249
[2]   Characteristics of Kawasaki disease in infants younger than six months of age [J].
Chang, FY ;
Hwang, B ;
Chen, SJ ;
Lee, PC ;
Meng, CCL ;
Lu, JH .
PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2006, 25 (03) :241-244
[3]   Hospitalizations for Kawasaki disease among children in the United States, 1988-1997 [J].
Chang, RKR .
PEDIATRICS, 2002, 109 (06) :e87
[4]  
Chuang Chih-Hsien, 2006, Journal of Microbiology Immunology and Infection, V39, P387
[5]  
DURONGPISITKUL K, 1995, PEDIATRICS, V96, P1057
[6]   Long-term consequences of Kawasaki disease - A 10- to 21-year follow-up study of 594 patients [J].
Kato, H ;
Sugimura, T ;
Akagi, T ;
Sato, N ;
Hashino, K ;
Maeno, Y ;
Kazue, T ;
Eto, G ;
Yamakawa, R .
CIRCULATION, 1996, 94 (06) :1379-1385
[7]  
Martinez Ruiz M, 2003, An Pediatr (Barc), V59, P323
[8]  
NAKAMURA Y, 1991, PEDIATRICS, V88, P1144
[9]   Diagnosis, treatment, and long-term management of Kawasaki disease: A statement for health professionals from the committee on rheumatic fever, endocarditis, and Kawasaki disease, Council on Cardiovascular Disease in the Young, American Heart Association [J].
Newburger, JW ;
Takahashi, M ;
Gerber, MA ;
Gewitz, MH ;
Tani, LY ;
Burns, JC ;
Shulman, ST ;
Bolger, AF ;
Ferrieri, P ;
Baltimore, RS ;
Wilson, WR ;
Baddour, LM ;
Levison, ME ;
Pallasch, TJ ;
Falace, DA ;
Taubert, KA .
PEDIATRICS, 2004, 114 (06) :1708-1733
[10]   Maternal antibody against toxic shock syndrome toxin-1 may protect infants younger than 6 months of age from developing Kawasaki syndrome [J].
Nomura, Y ;
Yoshinaga, M ;
Masuda, K ;
Takei, S ;
Miyata, K .
JOURNAL OF INFECTIOUS DISEASES, 2002, 185 (11) :1677-1680